ST does rare cancer double deal

By Megan Brodie 3 years ago | In Companies, Regulatory
  • 3 years ago

25 October 2021 Specialised Therapeutics (ST) has licenced two more rare cancer therapies for Australia,…

This is subscriber-only content. Please login to continue reading.